Objective
LIG Biowise Ltd specialises in the development of targeted nanodrugs and targeted nanodiagnostic systems. The company is now developing a next generation rapid diagnostic system for use by healthcare staff to quickly determine whether medical symptoms are a viral infection or bacterial infection. Many infectious diseases present with similar symptoms and it can be difficult to correctly diagnose and treat a patient without further diagnostic investigation.
Infectious diseases are one of the major cases of global morbidity and mortality, resulting in 16.2% of all deaths per year. The majority of these infectious diseases are a result of viral or bacterial pathogens. It is estimated that in the UK alone, over 10 million needless antibiotic prescriptions are written each year. This number includes prescriptions incorrectly given to patients suffering from viral infections. This is not only a waste of financial resources, but also leads to the development of drug resistant bacteria strains. This trend has been repeated worldwide, meaning that antibiotics are losing their effectiveness at an increasing rate and antibiotic resistance has become a worldwide problem. A diagnostic kit, such as the product proposed by LIG Biowise, will save millions of euros in costs associated with the over prescription of antibiotics for viral infections and lead to reductions in the number of drug resistant bacteria.
LIG Biowise’s rapid medical diagnostic kit will give healthcare staff a rapid diagnosis, while remaining technologically simple, have minimal training requirements and will not require expensive instrumentation. The SME Innovation Associate will play a crucial role in helping LIG Biowise reach this goal. They will also undertake a 12-month training programme, including; a mentoring scheme with academic and industrial leaders, opportunities to attend conferences, and full participation in EU core training programme.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences public health
- medical and health sciences health sciences infectious diseases RNA viruses influenza
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance antibiotic resistance
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
CSA - Coordination and support action
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-INNOSUP-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
B1 2AF BIRMINGHAM
United Kingdom
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.